Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.
about
Associations between purine metabolites and clinical symptoms in schizophreniaGenetic Sources of Subcomponents of Event-Related Potential in the Dimension of Psychosis Analyzed From the B-SNIP StudySchizophrenia: One Coat of Many ColorsTargeting Oxidative Stress and Aberrant Critical Period Plasticity in the Developmental Trajectory to Schizophrenia.Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophreniaSocial isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneuronsEffects of the antioxidant sulforaphane on hyperlocomotion and prepulse inhibition deficits in mice after phencyclidine administration.Glutamatergic modulation of auditory information processing in the human brain.Meta-analysis of oxidative stress in schizophrenia.Erythrocyte glutathione levels as long-term predictor of transition to psychosisLipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment.Oxidative stress-driven parvalbumin interneuron impairment as a common mechanism in models of schizophrenia.Quantitative analyses of schizophrenia-associated metabolites in serum: serum D-lactate levels are negatively correlated with gamma-glutamylcysteine in medicated schizophrenia patients.Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone.Altered glycogen metabolism in cultured astrocytes from mice with chronic glutathione deficit; relevance for neuroenergetics in schizophrenia.Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity.Associations between purine metabolites and monoamine neurotransmitters in first-episode psychosis.A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.Redox dysregulation, neuroinflammation, and NMDA receptor hypofunction: A "central hub" in schizophrenia pathophysiology?Glutathione deficit impairs myelin maturation: relevance for white matter integrity in schizophrenia patients.Biomarkers and clinical staging in psychiatryOxidative stress in older patients with bipolar disorder.An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients with Schizophrenia.Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects.Dietary Intake of Sulforaphane-Rich Broccoli Sprout Extracts during Juvenile and Adolescence Can Prevent Phencyclidine-Induced Cognitive Deficits at AdulthoodProlonged Period of Cortical Plasticity upon Redox Dysregulation in Fast-Spiking InterneuronsNiacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis.Meta-Analyses of Manganese Superoxide Dismutase Activity, Gene Ala-9Val Polymorphism, and the Risk of Schizophrenia.Angiogenic and immune signatures in plasma of young relatives at familial high-risk for psychosis and first-episode patients: A preliminary study.Antioxidants as potential therapeutics for neuropsychiatric disorders.A Role for the Transcription Factor Nk2 Homeobox 1 in Schizophrenia: Convergent Evidence from Animal and Human StudiesGlutathione Deficit Affects the Integrity and Function of the Fimbria/Fornix and Anterior Commissure in Mice: Relevance for SchizophreniaPerineuronal nets protect fast-spiking interneurons against oxidative stress.Cognitive and motivational deficits together with prefrontal oxidative stress in a mouse model for neuropsychiatric illness.Convergence of genetic and environmental factors on parvalbumin-positive interneurons in schizophrenia.Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers.Synaptic and cellular changes induced by the schizophrenia susceptibility gene G72 are rescued by N-acetylcysteine treatment.Role of immunological factors in the pathophysiology and diagnosis of bipolar disorder: comparison with schizophrenia.Pathological Implications of Oxidative Stress in Patients and Animal Models with Schizophrenia: The Role of Epidermal Growth Factor Receptor Signaling.Altering the course of schizophrenia: progress and perspectives.
P2860
Q21560779-82C73907-A17B-497A-826F-E04490105614Q27329481-7CB88951-37C5-40E1-9657-442C12FEAF28Q27500448-D2D596BB-0849-497D-AD52-1F3E762FF9D3Q30380519-8297F9ED-71FB-4110-B77E-D41E93CA2547Q30403518-5B191F50-7017-4E47-86A7-8AFAD15E87D8Q30438450-119E229E-BABB-4928-8B22-F54AB6CC8EEBQ30458051-29038ACD-93DD-4432-9F0C-4C5D3EC56589Q30506046-F35FD94A-61DC-4C98-B76F-572135AAA4F3Q33601360-CFC3EE26-EE8A-4002-ADFE-046F0EB62A4DQ33635566-A452EDA5-6263-4B42-837D-544D5842455DQ33787909-97140AF8-4C6A-42EE-93E4-9B003020F4EFQ33854995-58CC264D-9A6E-4C29-9EE0-62D5F6AB72FDQ33863985-61CD9BFF-2E6E-4768-BBB5-D25D3981ED91Q33904833-183F2E09-7BEF-46E5-92D8-63A3F3E96578Q33988027-5E23126B-270C-4925-B894-78535E6543E3Q34228522-F3007311-F656-4DA7-9885-5520A93616BFQ34351848-250449E0-9D4A-4D43-BE3A-AC41261B7F89Q34405264-1742EB60-6AC9-4E27-B303-37FAC67BBAB4Q34428194-83326CCB-F484-4D22-88FF-CBD326E1DB69Q34435048-46967F85-F755-48B2-9BB8-28D2C1026E91Q34447051-E9779427-DD89-4680-943E-E5C9165F4100Q34585536-F6C81670-C474-4415-A4F3-80D02F12CF55Q35579197-641ABCD6-0A63-4CF7-9197-D3AACA25CFD8Q35591134-4E9F84CC-98AD-40A5-B12A-4B53998D90C1Q35673126-84F4F08A-9262-45D3-A971-FF69512B6B5EQ35888156-048FD098-18B4-45A7-ABD7-B180DB3E2B8FQ35928509-CC5C2354-BC91-4688-B5A0-5417BDF41E78Q36194852-6A162940-3D3A-4507-B142-D16C2E73D2C9Q36526417-0372BFF5-E59B-456E-8C39-02281555D52FQ36736055-4B12DD80-46B0-40C3-97C0-31A666CF602AQ36740391-4E73F87F-640A-4315-9D95-F1F53E902FEEQ36749848-CE0B469C-EFC9-4E8D-8E9B-4C01D791BBC1Q36895825-0D61FD18-4FBA-424C-9605-B0075F3C6D31Q37049425-E76DCDEF-1B2E-4A86-BCF6-B19F21443DADQ37139004-5442C919-EB01-4F1C-AACE-977D2D730316Q37307208-622B8685-CE9D-48B1-B6A7-363278A879D4Q37349910-84C0C67E-EEC4-40E7-8707-DBB4BC8C294DQ38150488-3D10E708-6B5C-4F31-822C-9A8179065FF3Q38609431-1BB8B8A7-4EC5-495F-B827-A6963D4E7F3CQ38759421-8E4FEF92-F3BD-46BE-BE91-3BCEBD5756F5
P2860
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.
@ast
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.
@en
type
label
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.
@ast
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.
@en
prefLabel
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.
@ast
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.
@en
P2860
P356
P1476
Antioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.
@en
P2093
Jeffrey K Yao
P2860
P304
P356
10.1089/ARS.2010.3603
P577
2011-04-21T00:00:00Z